Compounds > my 5445

my 5445 and cyclic gmp

my 5445 has been researched along with cyclic gmp in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's6 (60.00)18.2507
2000's2 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
dos Santos, IR; Duarte, ID; Ferreira, SH; Lorenzetti, BB1
Duarte, ID; Ferreira, SH2
Duarte, ID; Ferreira, SH; Lorenzetti, BB1
Brazdil, R; Diocee, BK; Jordan, R; Souness, JE1
Moncada, S; Palmer, RM; Radomski, MW1
Ballou, LM; Edelmann, HM; Petritsch, C; Woscholski, R1
Ko, FN; Kuo, SC; Lee, FY; Teng, CM; Wu, CC1
Akamatsu, N; Inenaga, K; Yamashita, H1
Barile, L; Giacomello, A; Lupi, F; Messina, E1

Other Studies

10 other study(ies) available for my 5445 and cyclic gmp

ArticleYear
Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway.
    European journal of pharmacology, 1992, Jul-07, Volume: 217, Issue:2-3

    Topics: Acyclic Monoterpenes; Analgesics; Animals; Arginine; Bucladesine; Cyclic AMP; Cyclic GMP; Dipyrone; Male; Monoterpenes; Nitric Oxide; Nociceptors; omega-N-Methylarginine; Phthalazines; Rats; Rats, Wistar; Terpenes

1992
The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway.
    European journal of pharmacology, 1992, Oct-06, Volume: 221, Issue:1

    Topics: Analgesia; Animals; Arginine; Brain; Carbachol; Cyclic GMP; Dinoprostone; Male; Molsidomine; Morphine; Nitric Oxide; Ornithine; Phthalazines; Rats; Rats, Wistar

1992
The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release.
    European journal of pharmacology, 1991, Aug-16, Volume: 201, Issue:1

    Topics: Analgesia; Animals; Arginine; Cyclic GMP; Male; Methylene Blue; Molsidomine; Morphine; Nitric Oxide; Ornithine; Phthalazines; Rats; Rats, Inbred Strains

1991
Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.
    British journal of pharmacology, 1989, Volume: 98, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Aorta, Thoracic; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Kinetics; Male; Methylene Blue; Muscle Relaxants, Central; Nitric Oxide; Phthalazines; Purinones; Pyridazines; Rats; Rats, Inbred Strains; Theophylline; Vinca Alkaloids

1989
The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium.
    Biochemical and biophysical research communications, 1987, Nov-13, Volume: 148, Issue:3

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Aspirin; Blood Platelets; Collagen; Cyclic GMP; Endothelium, Vascular; Epoprostenol; Extracellular Matrix; Humans; In Vitro Techniques; Nitric Oxide; Phthalazines; Platelet Adhesiveness; Purinones; Superoxide Dismutase; Thrombin

1987
Activation of p70 S6 kinase and erk-encoded mitogen-activated protein kinases is resistant to high cyclic nucleotide levels in Swiss 3T3 fibroblasts.
    The Journal of biological chemistry, 1995, Nov-03, Volume: 270, Issue:44

    Topics: 3T3 Cells; 8-Bromo Cyclic Adenosine Monophosphate; Alprostadil; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activation; Epidermal Growth Factor; Kinetics; Mice; Mitogen-Activated Protein Kinases; Nerve Tissue Proteins; Nicotinic Acids; Phosphatidylinositol 3-Kinases; Phosphodiesterase Inhibitors; Phosphotransferases (Alcohol Group Acceptor); Phthalazines; Protein Serine-Threonine Kinases; Ribosomal Protein S6 Kinases; Signal Transduction; Theophylline

1995
YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
    British journal of pharmacology, 1995, Volume: 116, Issue:3

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Blood Platelets; Collagen; Cyclic AMP; Cyclic GMP; Dideoxyadenosine; Dose-Response Relationship, Drug; Enzyme Activation; Furans; Guanylate Cyclase; Hemoglobins; Humans; Indazoles; Nitric Oxide; Phosphodiesterase Inhibitors; Phthalazines; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Solubility; Thrombin; Thromboxane A2; Vasoconstrictor Agents

1995
Inhibitory effects of natriuretic peptides on vasopressin neurons mediated through cGMP and cGMP-dependent protein kinase in vitro.
    Journal of neuroendocrinology, 1993, Volume: 5, Issue:5

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Atrial Natriuretic Factor; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Electrophysiology; Enzyme Inhibitors; Isoquinolines; Male; Membrane Potentials; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Neurons; Phosphodiesterase Inhibitors; Phthalazines; Rats; Rats, Wistar; Second Messenger Systems; Supraoptic Nucleus; Vasopressins

1993
L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway.
    Mediators of inflammation, 2000, Volume: 9, Issue:1

    Topics: Analgesics; Animals; Arginine; Carrageenan; Cyclic GMP; Dinoprostone; Hyperalgesia; Male; Methylene Blue; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Oxadiazoles; Phosphodiesterase Inhibitors; Phthalazines; Quinoxalines; Rats; Rats, Wistar; Signal Transduction

2000
Cyclic nucleotides and neuroblastoma differentiation.
    Nucleosides, nucleotides & nucleic acids, 2004, Volume: 23, Issue:8-9

    Topics: Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Cyclic GMP; Dipyridamole; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Neuroblastoma; Nucleotides, Cyclic; Phosphodiesterase Inhibitors; Phthalazines; Purinones; Time Factors

2004